Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. R.A. (Robert) Schoevers

Publications

Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review

Inpatient dialectical behavior therapy combined with trauma-focused therapy for PTSD and borderline personality disorder symptoms: study design of the naturalistic trauma therapy study

Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers

Plasma esketamine and noresketamine levels and antidepressant response with oral esketamine treatment

Quality of reporting on psychological interventions in psychedelic treatments: a systematic review

The relationship between electric field strength induced by electroconvulsive therapy and cognitive and antidepressant outcomes

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression

Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies

Assessment of biomarker stability and assay performance parameters for medical diagnosis: a case study of diagnosis of major depressive disorder

Attitudes and Perceptions of Mental Healthcare Recipients and their Close Ones on Psychedelic Treatments: results from a Dutch Mixed Methods Survey

Press/media

Psychiater Robert Schoevers gaat op zoek naar betekenis

Farmaci psichedelici: al via il primo trial europeo sul distress nel fine vita

Wat hebben ketamine en depressie met elkaar te maken?

Trippend in de scanner: psilocybine heeft wekenlang effect op brein

UMCG neemt nieuw psychiatriegebouw in gebruik

UMCG heeft een nieuw, open en licht gebouw voor psychiatrie

‘MDMA en therapie mogelijk goed voor post-traumatische stress’

GGZ behandelplek van de toekomst – Channah Kruijt wint challenge